Genetic diversity of msp3α and msp1 _b5 markers of Plasmodium vivax in French Guiana
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetic diversity of msp3α and msp1 _b5 markers of Plasmodium vivax in French Guiana ; volume:8 ; number:1 ; day:11 ; month:3 ; year:2009 ; pages:1-8 ; date:12.2009
Malaria journal ; 8, Heft 1 (11.3.2009), 1-8, 12.2009
- Creator
-
Véron, Vincent
- Contributor
-
Legrand, Eric
Yrinesi, Joséphine
Volney, Beatrice
Simon, Stéphane
Carme, Bernard
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-8-40
- URN
-
urn:nbn:de:1111-2016080613828
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Véron, Vincent
- Legrand, Eric
- Yrinesi, Joséphine
- Volney, Beatrice
- Simon, Stéphane
- Carme, Bernard
- SpringerLink (Online service)
Other Objects (12)
Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana
Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana
Deforestation, agriculture and farm jobs: a good recipe for Plasmodium vivax in French Guiana
Frequency and distribution of mixed Plasmodium falciparum-vivax infections in French Guiana between 2000 and 2008
Orchids of French Guiana
Plasmodium vivax: who cares?
Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors
Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Severe Plasmodium vivax infection in Korea
The anaemia of Plasmodium vivax malaria
Plasmodium vivax trophozoites insensitive to chloroquine
Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana
Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana
Deforestation, agriculture and farm jobs: a good recipe for Plasmodium vivax in French Guiana
Frequency and distribution of mixed Plasmodium falciparum-vivax infections in French Guiana between 2000 and 2008
Orchids of French Guiana
Plasmodium vivax: who cares?
Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors
Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Severe Plasmodium vivax infection in Korea
The anaemia of Plasmodium vivax malaria
Plasmodium vivax trophozoites insensitive to chloroquine
Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana
Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana
Deforestation, agriculture and farm jobs: a good recipe for Plasmodium vivax in French Guiana
Frequency and distribution of mixed Plasmodium falciparum-vivax infections in French Guiana between 2000 and 2008
Orchids of French Guiana
Plasmodium vivax: who cares?
Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors
Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison
Severe Plasmodium vivax infection in Korea
The anaemia of Plasmodium vivax malaria